BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

931 related articles for article (PubMed ID: 19477273)

  • 1. Formation of indomethacin-saccharin cocrystals using supercritical fluid technology.
    Padrela L; Rodrigues MA; Velaga SP; Matos HA; de Azevedo EG
    Eur J Pharm Sci; 2009 Aug; 38(1):9-17. PubMed ID: 19477273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indomethacin-saccharin cocrystal: design, synthesis and preliminary pharmaceutical characterization.
    Basavoju S; Boström D; Velaga SP
    Pharm Res; 2008 Mar; 25(3):530-41. PubMed ID: 17703346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Powder X-ray diffraction method for the quantification of cocrystals in the crystallization mixture.
    Padrela L; de Azevedo EG; Velaga SP
    Drug Dev Ind Pharm; 2012 Aug; 38(8):923-9. PubMed ID: 22092083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. pH-dependent solubility of indomethacin-saccharin and carbamazepine-saccharin cocrystals in aqueous media.
    Alhalaweh A; Roy L; Rodríguez-Hornedo N; Velaga SP
    Mol Pharm; 2012 Sep; 9(9):2605-12. PubMed ID: 22867056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thermal analysis and FTIR spectral curve-fitting investigation of formation mechanism and stability of indomethacin-saccharin cocrystals via solid-state grinding process.
    Zhang GC; Lin HL; Lin SY
    J Pharm Biomed Anal; 2012 Jul; 66():162-9. PubMed ID: 22497855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of electrospray deposition for rapid screening of the cocrystal formation and single step, continuous production of pharmaceutical nanococrystals.
    Emami S; Siahi-Shadbad M; Barzegar-Jalali M; Adibkia K
    Drug Dev Ind Pharm; 2018 Jun; 44(6):1034-1047. PubMed ID: 29347850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and pharmaceutical characterization of amorphous cefdinir using spray-drying and SAS-process.
    Park J; Park HJ; Cho W; Cha KH; Kang YS; Hwang SJ
    Int J Pharm; 2010 Aug; 396(1-2):239-45. PubMed ID: 20599602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation of phenytoin nanoparticles using rapid expansion of supercritical solution with solid cosolvent (RESS-SC) process.
    Thakur R; Gupta RB
    Int J Pharm; 2006 Feb; 308(1-2):190-9. PubMed ID: 16352406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Near-infrared spectroscopy for cocrystal screening. A comparative study with Raman spectroscopy.
    Allesø M; Velaga S; Alhalaweh A; Cornett C; Rasmussen MA; van den Berg F; de Diego HL; Rantanen J
    Anal Chem; 2008 Oct; 80(20):7755-64. PubMed ID: 18798651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics Study of Cocrystal Formation Between Indomethacin and Saccharin Using High-Shear Granulation With In Situ Raman Spectroscopy.
    Tanaka R; Hattori Y; Ashizawa K; Otsuka M
    J Pharm Sci; 2019 Oct; 108(10):3201-3208. PubMed ID: 31279736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recrystallization of fluconazole using the supercritical antisolvent (SAS) process.
    Park HJ; Kim MS; Lee S; Kim JS; Woo JS; Park JS; Hwang SJ
    Int J Pharm; 2007 Jan; 328(2):152-60. PubMed ID: 16959448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supercritical fluid assisted atomization introduced by an enhanced mixer for micronization of lysozyme: Particle morphology, size and protein stability.
    Du Z; Guan YX; Yao SJ; Zhu ZQ
    Int J Pharm; 2011 Dec; 421(2):258-68. PubMed ID: 22001535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.
    Fini A; Cavallari C; Ospitali F
    Eur J Pharm Biopharm; 2008 Sep; 70(1):409-20. PubMed ID: 18621516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physicochemical and mechanical properties of carbamazepine cocrystals with saccharin.
    Rahman Z; Samy R; Sayeed VA; Khan MA
    Pharm Dev Technol; 2012; 17(4):457-65. PubMed ID: 21265708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of indomethacin-saccharin (IMC-SAC) co-crystals prepared by an anti-solvent crystallization process.
    Chun NH; Wang IC; Lee MJ; Jung YT; Lee S; Kim WS; Choi GJ
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):854-61. PubMed ID: 23454054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of supercritical fluid technology as preparative technique of benzocaine-cyclodextrin complexes--comparison with conventional methods.
    Al-Marzouqi AH; Jobe B; Dowaidar A; Maestrelli F; Mura P
    J Pharm Biomed Anal; 2007 Jan; 43(2):566-74. PubMed ID: 17010552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioavailability of indomethacin-saccharin cocrystals.
    Jung MS; Kim JS; Kim MS; Alhalaweh A; Cho W; Hwang SJ; Velaga SP
    J Pharm Pharmacol; 2010 Nov; 62(11):1560-8. PubMed ID: 21039541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation, characterization and in vivo assessment of the bioavailability of glycyrrhizic acid microparticles by supercritical anti-solvent process.
    Sui X; Wei W; Yang L; Zu Y; Zhao C; Zhang L; Yang F; Zhang Z
    Int J Pharm; 2012 Feb; 423(2):471-9. PubMed ID: 22183131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) process.
    Kim MS; Jin SJ; Kim JS; Park HJ; Song HS; Neubert RH; Hwang SJ
    Eur J Pharm Biopharm; 2008 Jun; 69(2):454-65. PubMed ID: 18359211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vibrational spectroscopic investigation of polymorphs and cocrystals of indomethacin.
    Ali HR; Alhalaweh A; Velaga SP
    Drug Dev Ind Pharm; 2013 May; 39(5):625-34. PubMed ID: 22480325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.